These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26791530)

  • 1. Gender-Dependent Pharmacokinetics of Veratramine in Rats: In Vivo and In Vitro Evidence.
    Lyu C; Zhang Y; Zhou W; Zhang S; Kou F; Wei H; Zhang N; Zuo Z
    AAPS J; 2016 Mar; 18(2):432-44. PubMed ID: 26791530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of in vitro and in vivo metabolites of steroidal alkaloid veratramine.
    Lyu C; Zhou W; Zhang Y; Zhang S; Kou F; Wei H; Zhang N; Zuo Z
    Biopharm Drug Dispos; 2015 Jul; 36(5):308-24. PubMed ID: 25765359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Veratramine and Jervine from Alcohol Extracts of Radix Veratri.
    Wang S; Cui J; Zhao G; Liu H; Wang J
    Comput Math Methods Med; 2022; 2022():8289548. PubMed ID: 35785141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and metabolism study of veratramine in mice after oral administration using LC-MS/MS.
    Cong Y; Zhang JL; Li SS; Shen S; Wang JY; Cai Z
    Biomed Chromatogr; 2016 Sep; 30(9):1515-22. PubMed ID: 26972867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive effect and toxicology of total alkaloids and veratramine from roots and rhizomes of Veratrum nigrum L. in spontaneously hypertensive rats.
    Wang L; Li W; Liu Y
    Pharmazie; 2008 Aug; 63(8):606-10. PubMed ID: 18771011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism Study of Veratramine Associated with Neurotoxicity by Using HPLC-MSn.
    Cong Y; Guo J; Tang Z; Lin S; Zhang Q; Li J; Cai Z
    J Chromatogr Sci; 2015 Aug; 53(7):1092-9. PubMed ID: 25547283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
    Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
    J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats.
    Jeong DW; Kim YH; Kim HH; Ji HY; Yoo SD; Choi WR; Lee SM; Han CK; Lee HS
    Biopharm Drug Dispos; 2007 Mar; 28(2):51-7. PubMed ID: 17163409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
    Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
    Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in corydaline pharmacokinetics in rats.
    Jung JW; Choi MR; Kwon YS; Jeong JS; Son M; Kang HE
    Xenobiotica; 2015 May; 45(5):456-63. PubMed ID: 25430796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, protein binding, pharmacokinetics and excretion of the anti-ischemic and anti-hypertensive arylpiperazine derivative CDRI-93/478 in rats.
    Lal J; Gupta RC
    Arzneimittelforschung; 2008; 58(2):62-70. PubMed ID: 18412019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro/in vivo investigations to examine the gender differences in the pharmacokinetics of novel oral Janus kinase (JAK) inhibitor ASP015K and sulfate metabolite M2 in rats.
    Oda K; Nakada N; Nagasaka Y
    Xenobiotica; 2015; 45(6):488-94. PubMed ID: 25539455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of 4-O-methylhonokiol in rats.
    Yu HE; Oh SJ; Ryu JK; Kang JS; Hong JT; Jung JK; Han SB; Seo SY; Kim YH; Park SK; Kim HM; Lee K
    Phytother Res; 2014 Apr; 28(4):568-78. PubMed ID: 23824979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, oral bioavailability and metabolism of a novel isoquinolinone-based melatonin receptor agonist in rats.
    Zhu J; Hu Y; Ho MK; Wong YH
    Xenobiotica; 2012 Nov; 42(11):1138-50. PubMed ID: 22642804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway.
    Smith S; Hoyt J; Whitebread N; Manna J; Peluso M; Faia K; Campbell V; Tremblay M; Nair S; Grogan M; Castro A; Campbell M; Ferguson J; Arsenault B; Nevejans J; Carter B; Lee J; Dunbar J; McGovern K; Read M; Adams J; Constan A; Loewen G; Sydor J; Palombella V; Soglia J
    Xenobiotica; 2013 Oct; 43(10):875-85. PubMed ID: 23527529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.